advertisement

WGA Rescources

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (17)

Showing records 1 to 17

Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
57207 Increased Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Expression in the Conjunctival Epithelium Exposed to Antiglaucoma Treatments
Labbé A; Gabison E; Brignole-Baudouin F; Riancho L; Menashi S; Baudouin C
Current Eye Research 2014; 0: 1-8
56875 Scleral permeability varies by mouse strain and is decreased by chronic experimental glaucoma
Pease ME; Oglesby EN; Cone-Kimball E; Jefferys JL; Steinhart MR; Kim AJ; Hanes J; Quigley HA
Investigative Ophthalmology and Visual Science 2014; 55: 2564-2573
57127 Ocular surface changes in glaucomatous patients treated with and without preservatives beta-blockers
Iester M; Telani S; Frezzotti P; Motolese I; Figus M; Fogagnolo P; Perdicchi A;
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 476-481
57343 Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension
Sanford M
Clinical Drug Investigation 2014; 34: 521-528
57273 Trans-conjunctival aqueous humor outflow in glaucomatous patients treated with prostaglandin analogues: an in vivo confocal microscopy study
Mastropasqua R; Fasanella V; Pedrotti E; Lanzini M; Di Staso S; Mastropasqua L; Agnifili L
Graefe's Archive for Clinical and Experimental Ophthalmology 2014; 252: 1469-1476
57348 Effects of Polyquaternium- and Benzalkonium-Chloride-Preserved Travoprost on Ocular Surfaces: An Impression Cytology Study
Sezgin Akçay BI; Güney E; Bozkurt TK; Topal CS; Akkan JC; Unlü C
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 548-553
57537 Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma
Dubey A; Prabhu P
International journal of pharmaceutical investigation 2014; 4: 112-118
57250 Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition
Nakano M; Lockhart CM; Kelly EJ; Rettie AE
Drug Metabolism Reviews 2014; 46: 247-260
57354 Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: Towards non-invasive glaucoma gene therapy
Alqawlaq S; Sivak JM; Huzil JT; Ivanova MV; Flanagan JG; Beazely MA; Foldvari M
Nanomedicine: Nanotechnology, Biology, and Medicine 2014; 10: 1637-1647
57517 Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension
Bhagat P; Sodimalla K; Paul C; Pandav SS; Raman GV; Ramakrishnan R; Joshi A; Raut A
Clinical Ophthalmology 2014; 8: 1241-1252
57382 24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost
Konstas AG; Voudouragkaki IC; Boboridis KG; Haidich AB; Paschalinou E; Giannopoulos T; Dragoumis ND; Makridis AK; Kahook MY
Advances in Therapy 2014; 31: 592-603
57331 Controlled ocular drug delivery with nanomicelles
Vaishya RD; Khurana V; Patel S; Mitra AK
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2014; 6: 422-437
57479 28-day intraocular pressure reduction with a single dose of brimonidine tartrate-loaded microspheres
Fedorchak MV; Conner IP; Medina CA; Wingard JB; Schuman JS; Little SR
Experimental Eye Research 2014; 125: 210-216
57435 Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery
Xi L; Wang T; Zhao F; Zheng Q; Li X; Luo J; Liu J; Quan D; Ge J
PLoS ONE 2014; 9: e100632
57492 The effects of topical antiglaucoma drugs as monotherapy on the ocular surface: a prospective study
Aydin Kurna S; Acikgoz S; Altun A; Ozbay N; Sengor T; Olcaysu OO
Journal of Ophthalmology 2014; 2014: 460483
57475 Advances in ocular drug delivery: emphasis on the posterior segment
Kang-Mieler JJ; Osswald CR; Mieler WF
Expert Opinion on Drug Delivery 2014; 0: 1-14
57064 Objective evaluation of applying eye drops by elderly patients
Colomé-Campos J; Martínez-Salcedo I; Martorell-Hallado MC; Romero-Aroca P
Archivos de la Sociedad EspaƱola de Oftalmologia 2014; 89: 177-181

Issue 16-2

Change Issue


advertisement

Oculus